Snowball logo
logo
ALC_logo

Alcon AG

$74.25+$0.73ย  (0.99%)
Estimate
P/E
55.4
EPS
1.34
Beta
0.693
Growth
Revenue, YoY
7.3%
Net income, YoY
-47.05%
FCF, YoY
12.12%
Forecast
P/E (FWD)
18.7
EPS (FWD)
3.971
Dividends
Dividend yield
0.48%
Annual payout
$0.36
Next ex. div date
May 6, 27
Payout
21.02%
Div.growth, 5y
11.82%
Dividend growth streak
4 y
Div.rating
About the company
Ticker
ALC
ISIN
CH0432492467
Country
Switzerland
Sector (GICS)
Healthcare
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Frequently asked questions

What sector does Alcon AG (ALC) operate in?

Alcon AG belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.

What is Alcon AG (ALC) current stock price?

As of the latest data, Alcon AG stock price is $74.25, with a previous close of $73.52. Alcon AG gained $0.73 in the last trading session, representing a 0.99% increase.

What is Alcon AG (ALC) current market capitalization?

Alcon AG market cap is approximately 35.89 billion.

What is Alcon AG (ALC) Earnings Per Share (EPS)?

The trailing EPS is $1.34, and the forward EPS is $3.97.

What is Alcon AG (ALC) Price-to-Earnings (P/E) ratio?

Alcon AG current P/E ratio is 55.41, with a forward P/E of 18.7.

What is Alcon AG (ALC) EBITDA?

Alcon AG EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 564.81 million.

Does Alcon AG (ALC) pay dividends?

Yes. Alcon AG pays annual dividends with an annualized yield of 0.48% and an estimated annual payout of $0.36 per share.

When is the next ex-dividend date for Alcon AG (ALC)?

The next ex-dividend date is scheduled for May 06, 2027.

How did Alcon AG (ALC) perform in its most recent earnings report?

In the last report (June 30, 2026), Alcon AG posted an EPS surprise of 3.66% and a revenue surprise of -2.13%.

What is Alcon AG (ALC) beta (volatility) score?

Alcon AG has a beta of 0.693, indicating lower volatility than the overall market.